New England Biolabs, Inc. is a leading biotechnology company based in Ipswich, Massachusetts, specializing in nucleic acid technologies. The company develops and manufactures a wide range of products for genomic research, including enzymes for DNA assembly, RNA capping, and high-throughput applications. NEB is recognized for its innovative enzymatic methods and modified nucleotides, catering to the needs of researchers in molecular biology and genetics. Its commitment to advancing scientific discovery is reflected in its extensive portfolio of reagents and tools.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

345 Patents

#1 in Ipswich, MA

#72 in Massachusetts

#1,310 in US

#2,641 in the World

Ipswich, MA, United States of America

New England Biolabs, Inc.

Forward Citations = 3,183

254 inventors:

Shuang-Yong Xu (61 out of 63 patents)

Shengxi Guan (35 out of 37 patents)

Zhenyu Zhu (34 out of 36 patents)

4. Thomas C Evans, Jr (31 out of 34 patents)

5. Christopher H Taron (28 out of 28 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: New England Biolabs, Inc.. Retrieved from https://idiyas.com/company/new-england-biolabs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

68 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]